Effect of conjugated linoleic acid on inhibition of prolyl hydroxylase 1 in hearts of mice

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Zhang, Jize ^a   Li, Defa ^a,b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b State Key Laboratories for Agrobiotechnology   (China)

Author keywords

CLA; HIF 2; PDK4; PPAR

Indexed keywords

CONJUGATED LINOLEIC ACID; GLUCOSE TRANSPORTER 4; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; OXYGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROLYL HYDROXYLASE 1; PYRUVATE DEHYDROGENASE KINASE 4; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CARDIOTONIC AGENT; CARNITINE PALMITOYLTRANSFERASE; CPT1B PROTEIN, MOUSE; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2; PHD1 PROTEIN, MOUSE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL TRANSFERRING) KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; SLC2A4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HEART; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART PROTECTION; ISOMER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; RANDOMIZATION; STEREOISOMERISM;

MUS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARDIOTONIC AGENTS; CARNITINE O-PALMITOYLTRANSFERASE; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 4; HEART; HYPOXIA-INDUCIBLE FACTOR 1; ION CHANNELS; LINOLEIC ACIDS, CONJUGATED; MICE; MICE, INBRED ICR; MITOCHONDRIAL PROTEINS; MYOCARDIUM; PPAR ALPHA; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN-SERINE-THREONINE KINASES; RANDOM ALLOCATION; STEREOISOMERISM;

EID: 84856568640     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-22     Document Type: Article

References (60)

1. Global atlas on cardiovascular disease prevention and control, WHO; World Heart Federation; World Stroke Organization 2011
2. Hypoxia-inducible factor as a physiological regulator. Maxwell, Exp Physiol 2005 90 6 791 797
3. HIF and oxygen sensing; as important to life as the air we breathe? Wiesener MS, Maxwell PH, Ann Med 2003 35 3 183 190 (Pubitemid 36765231)
4. 2-regulated prolyl hydroxylation. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliff PJ, Science 2001 292 5516 468 472 (Pubitemid 32335942)
5. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Aragonés J, Schneider M, Van Geyte K, Fraisl P, et al. Nat Genet 2008 40 170 180 (Pubitemid 351171394)
6. C. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ, Cell 2001 107 1 43 54 (Pubitemid 32972036)
7. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Hon WC, Wilson MI, Harlos K, Claridge TDW, Schofield CJ, Pugh CW, Maxwell PH, Ratcliffe PJ, Stuart DI, Jones EY, Nature 2002 417 975 978 (Pubitemid 34716877)
8. 2 sensing. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG, Science 2001 292 5516 464 468 (Pubitemid 32335941)
9. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe RJ, Nature 1999 399 271 275 (Pubitemid 29246458)
10. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V, Kaelin WG, Nat Cell Biol 2000 2 7 423 427
11. Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway. Kaelin William G Jr, Ratcliffe Peter J, Mol Cell 2008 30 4 393 402
12. HIF-1 as a target for drug development. Giaccia A, Siim BG, Johnson RS, Nat Rev Drug Discov 2003 2 10 803 811 (Pubitemid 37361812)
13. The HIF pathway as a therapeutic target. Hewitson KS, Schofield CJ, Drug Discov Today 2004 9 16 704 711 (Pubitemid 39070283)
14. Intermediates and products of biohydrogenation of linoleic acid by Butyrivibrio fibrisolven. Kepler CR, Hirons KP, McNeill JJ, Tove SB, J Biol Chem 1966 241 1350 1354
15. The biologically active isomers of conjugated linoleic acid. Priza MW, Park Y, Cook ME, Prog Lipid Res 2001 40 4 283 298 (Pubitemid 32547235)
16. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Priza MW, Park Y, Cook ME, Proc Soc Exp Biol Med 2000 223 1 8 13 (Pubitemid 30182652)
17. Role of the conjugated linoleic acid in the prevention of cancer. Lee KW, Lee HJ, Cho HY, Kim YJ, Crit Rev Food Sci Nutr 2005 45 2 251 258
18. Conjugated linoleic acid isomers and cancer. Kelly NS, Hubbard NE, Erickson KL, J Nutr 2007 137 12 2599 2607 (Pubitemid 350255285)
19. Conjugated linoleic acid isomers and mammary cancer prevention. Ip C, Dong Y, Ip MM, Banni S, Carta G, Angioni E, Murru E, Spada S, Melis MP, Saebo A, Nutr Cancer 2002 43 1 52 58 (Pubitemid 35387256)
20. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker S, Ramirez RA, Ip MM, Cancer Res 2002 62 15 4383 4389 (Pubitemid 34827297)
21. Conjugated linoleic acid decreases hepatic stearoyl-CoA desaturase mRNA expression. Lee KN, Pariza MW, Ntambi JM, Biochem Biophys Res Commun 1998 248 3 817 821 (Pubitemid 28404506)
22. Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Kritchevsky D, Tepper SA, Wright S, Czarnecki SK, Wilson TA, Nicolosi RJ, Lipids 2004 39 7 611 616 (Pubitemid 39488878)
23. Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Park Y, Pariza MW, Food Res Int 2007 40 3 311 323 (Pubitemid 46124004)
24. Tran-10, ci-12- and ci-9, tran-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. Arbonés-Mainar JM, Navarro MA, Acín S, Guzmán MA, Arnal C, Surra JC, Carnicer R, Roche HM, Osada J, J Nutr 2006 136 2 353 359 (Pubitemid 43228286)
25. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW, Lipids 1999 34 3 235 241 (Pubitemid 29169626)
26. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Cook ME, Miller CC, Park Y, Pariza M, Poult Sci 1993 72 7 1301 1305
27. Colonic anti-inflammatory mechanisms of conjugated linoleic acid. Bassaganya-Riera J, Hontecillas R, Beitz DC, Clin Nutr 2002 21 6 451 459 (Pubitemid 35452508)
28. Effects of conjugated linoleic acid on growth and cytokine expression in Jurkat T cells. Luongo D, Bergamo P, Rossi M, Immunol Lett 2003 90 2-3 195 201 (Pubitemid 37548477)
29. Nutritional supplementation with tran-10, ci-12-conjugated linoleic acid induces inflammation of white adipose tissue. Poirier H, Shapiro JS, Kim RJ, Lazar MA, Diabetes 2006 55 6 1634 1641 (Pubitemid 44324115)
30. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, Kasai M, Ikemoto S, Ezaki O, Diabetes 2000 49 9 1534 1542
31. Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. Clément L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, Staels B, Besnard P, J Lipid Res 2002 43 9 1400 1409
32. Trans-10, cis-12-CLA dysregulate lipid and glucose metabolism and induce hepatic NR4A receptors. Navarro MA, Badimon L, Rodriguez C, Arnal C, Noone EJ, Roche HM, Osada J, Martinez-Gonzalez J, Front Biosci (Elite Ed) 2010 2 87 97
33. Conjugated linoleic acid in adipose tissue and risk of myocardial infarction. Smit LA, Baylin A, Campos H, Am J Clin Nutr 2010 92 1 34 40
34. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J, Am J Physiol 1998 275 3 Pt 2 667 672
35. Effect of conjugated linoleic acid on body composition in mice. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW, Lipids 1997 32 8 853 858 (Pubitemid 27360392)
36. The decrease in body fat in mice fed conjugated linoleic acid is due to increases in energy expenditure and energy loss in the excreta. Terpstra AH, Beynen AC, Everts H, Kocsis S, Katan MB, Zock PL, J Nutr 2002 132 940 945 (Pubitemid 34493557)
37. The effects of t10, c12 CLA isomer compared with c9, t11 CLA isomer on lipid metabolism and body composition in hamsters. Bissonauth V, Chouinard Y, Marin J, Leblanc N, Richard D, Jacques H, J Nutr Biochem 2006 17 9 597 603 (Pubitemid 44205439)
38. Effects of conjugated linoleic acid (CLA) isomers on lipid levels and peroxisome proliferation in the hamster. de Deckere EA, van Amelsvoort JM, McNeill GP, Jones P, Br J Nutr 1999 82 4 309 317 (Pubitemid 29481517)
39. Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. Sisk MB, Hausman DB, Martin RJ, Azain MJ, J Nutr 2001 131 1668 1674 (Pubitemid 32520430)
40. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signaling. Berra E, Ginouvès A, Pouysségur J, EMBO Rep 2006 7 1 41 45
41. Prolyl hydroxylase inhibitors depend on extracellular glucose and Hypoxia-Inducible Factor (HIF)-2 to inhibit cell death caused by Nerve Growth Factor (NGF) deprivation: evidence that HIF-2 has a role in NGF-promoted survival of sympathetic neurons. Lomb David J, Desouza Lynette A, Franklin James L, Freeman Robert S, Mol Pharmacol 2009 75 5 1198 1209
42. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K, Yang H, Sorokina I, Conaway RC, Conaway JW, Kaelin WG Jr, Proc Natl Acad Sci 2002 99 13459 13464 (Pubitemid 35215403)
43. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. Warnecke C, Griethe W, Weidemann A, Jurgensen JS, Willam C, Bachmann S, Ivashchenko Y, Wagner I, Frei U, Wiesener M, Eckardt KU, FASEB J 2003 17 9 1186 1188
44. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. Hyvarinen Jaana, Hassinen Ilmo E, Sormunen Raija, Maki Joni M, Kivirikko Kari I, Koivunen Peppi, Myllyharju Johanna, J Biol Chem
45. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA, Circ Res 2006 98 1 133 140 (Pubitemid 43970213)
46. 2) culture of human embryonic stem cells. Forsyth NR, Kay A, Hampson K, Downing A, Talbot R, McWhir J, Regen Med 2008 3 817 833
47. Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Westfall SD, Sachdev S, Das P, Hearne LB, Hannink M, Roberts RM, Ezashi T, Stem Cells Dev 2008 17 869 882
48. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Huang LE, Gu J, Schau M, Bunn HF, Proc Natl Acad Sci USA 1998 95 14 7987 7992
49. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Lang KJ, Kappel A, Goodall GJ, Mol Biol Cell 2002 13 5 1792 1801 (Pubitemid 34522656)
50. Hypoxic reprogramming. Kelly D, Nat Genet 2008 40 2 132 134 (Pubitemid 351171410)
51. Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Wu P, Peters JM, Harris RA, Biochem Biophys Res Commun 2001 287 2 391 396 (Pubitemid 32917610)
52. Coordinate expression of the PDK4 gene: a means of regulating fuel selection in a hibernating mammal. Buck MJ, Squire TL, Andrews MT, Physiol Genomics 2002 8 1 5 13 (Pubitemid 135707296)
53. Conjugated nonadecadienoic acid is more potent than conjugated linoleic acid on body fat reduction. Park Y, Park Y, J Nutr Biochem 2010 21 8 764 773
54. The Mitochondrial Carnitine Palmitoyltransferase System-From Concept to Molecular Analysis. McGarry D, Brown NF, Eur J Biochem 1997 244 1 1 14 (Pubitemid 27079689)
55. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Brand MD, Esteves TC, Cell Metab 2005 2 2 85 93
56. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Brand MD, Pamplona R, Portero-Otín M, Requena JR, Roebuck SJ, Buckingham JA, Clapham JC, Cadenas S, Biochem J 2002 368 Pt 2 597 603 (Pubitemid 35454538)
57. Mitochondrial ROS metabolism: modulation by uncoupling proteins. Casteilla L, Rigoulet M, Pénicaud L, IUBMB life 2001 52 3-5 181 188 (Pubitemid 33731571)
58. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Guzy RD, Schumacker PT, Exp Physiol 2006 91 5 807 819 (Pubitemid 44266577)
59. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, Ricquier D, Nat Genet 2000 26 4 435 439
60. Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Cortez-Pinto H, Zhi Lin H, Qi Yang S, Odwin Da Costa S, Diehl AM, Gastroenterol 1999 116 5 1184 1193 (Pubitemid 29203029)